Biolargo, Inc. financial data

Symbol
BLGO on OTC
Location
14921 Chestnut St., Westminster, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 233 % -0.26%
Quick Ratio 10.4 % +60.7%
Debt-to-equity 61.1 % +10%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 309M shares +2.78%
Common Stock, Shares, Outstanding 293M shares +5.2%
Entity Public Float 61.4M USD +50.1%
Common Stock, Value, Issued 205K USD +2.5%
Weighted Average Number of Shares Outstanding, Basic 303M shares +2.28%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.8M USD +10.4%
Operating Income (Loss) -6.34M USD -51.1%
Nonoperating Income (Expense) -80K USD -173%
Earnings Per Share, Basic 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.47M USD -27.2%
Accounts Receivable, after Allowance for Credit Loss, Current 1.74M USD -17.5%
Inventory, Net 444K USD +152%
Assets, Current 9.19M USD +29.2%
Property, Plant and Equipment, Net 1.66M USD -8.12%
Operating Lease, Right-of-Use Asset 937K USD -10.2%
Other Assets, Noncurrent 102K USD +45.7%
Assets 12.5M USD +24.3%
Accounts Payable, Current 1.18M USD -20.1%
Employee-related Liabilities, Current 253K USD +772%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 4.08M USD +35.5%
Operating Lease, Liability, Noncurrent 872K USD -9.64%
Liabilities 6.44M USD +54.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -203K USD +16.1%
Retained Earnings (Accumulated Deficit) -152M USD -2.64%
Stockholders' Equity Attributable to Parent 8.76M USD +45.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.06M USD +2.85%
Liabilities and Equity 12.5M USD +24.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.83M USD -480%
Net Cash Provided by (Used in) Financing Activities 866K USD -20%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 550M shares 0%
Common Stock, Shares, Issued 307M shares +2.89%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -984K USD -223%
Interest Paid, Excluding Capitalized Interest, Operating Activities 37K USD +208%
Deferred Tax Assets, Valuation Allowance 22.5K USD +1.14%
Operating Lease, Liability 977K USD -8.69%
Depreciation 159K USD +23.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.86M USD -34.9%
Lessee, Operating Lease, Liability, to be Paid 1.59M USD
Property, Plant and Equipment, Gross 2.2M USD
Operating Lease, Liability, Current 105K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 276K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 326K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.18 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 616K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 166K USD
Deferred Tax Assets, Operating Loss Carryforwards 22.5K USD +1.14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 170K USD
Additional Paid in Capital 161M USD +4.29%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 45K USD -47.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%